Your browser doesn't support javascript.
loading
Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort.
Wu, Xin-Yao; Yang, Min; Xie, Yue-Sheng; Xiao, Wei-Guo; Lin, Jin; Zhou, Bin; Guan, Xin; Luo, Cai-Nan; Che, Nan; Liu, Xing-Zhen; Wang, Chao; Teng, Jia-Lin; Cheng, Xiao-Bing; Ye, Jun-Na; Su, Yu-Tong; Shi, Hui; Yin, Yu-Feng; Liu, Meng-Ru; Sun, Yue; Hu, Qiong-Yi; Zhou, Zhuo-Chao; Chi, Hui-Hui; Liu, Yi; Zhang, Xiao; Chen, Jin-Wei; Zhang, Miao-Jia; Zhao, Dong-Bao; Yang, Cheng-de; Wu, Li-Jun; Liu, Hong-Lei.
Afiliación
  • Wu XY; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Yang M; Department of Rheumatology and Immunology, Sichuan University West China Hospital, Chengdu, China.
  • Xie YS; Department of Rheumatology and Immunology, Guangdong General Hospital, Guangzhou, China.
  • Xiao WG; Department of Rheumatology and Immunology, The First Hospital Affiliated to China Medical University, Shenyang, China.
  • Lin J; Department of Rheumatology and Immunology, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou, China.
  • Zhou B; Department of Rheumatology and Immunology, Sichuan People's Hospital, Chengdu, China.
  • Guan X; Department of Rheumatology and Immunology, Second Xiangya Hospital, Changsha, China.
  • Luo CN; Department of Rheumatology and Immunology, Xinjiang Uygur People's Hospital, No. 91 Tianchi Road, Tianshan District, Urumqi, 830001, Xinjiang Uygur Autonomous Region, China.
  • Che N; Department of Rheumatology and Immunology, Jiangsu People's Hospital, Nanjing, China.
  • Liu XZ; Department of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
  • Wang C; Beijing Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Fourth Clinical Medical College, Peking University, Beijing, China.
  • Teng JL; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Cheng XB; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Ye JN; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Su YT; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Shi H; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Yin YF; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Liu MR; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Sun Y; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Hu QY; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Zhou ZC; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Chi HH; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China.
  • Liu Y; Department of Rheumatology and Immunology, Sichuan University West China Hospital, Chengdu, China.
  • Zhang X; Department of Rheumatology and Immunology, Guangdong General Hospital, Guangzhou, China.
  • Chen JW; Department of Rheumatology and Immunology, Second Xiangya Hospital, Changsha, China.
  • Zhang MJ; Department of Rheumatology and Immunology, Jiangsu People's Hospital, Nanjing, China.
  • Zhao DB; Department of Rheumatology and Immunology, Changhai Hospital, Shanghai, China.
  • Yang CD; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China. yangchengde@sina.com.
  • Wu LJ; Department of Rheumatology and Immunology, Xinjiang Uygur People's Hospital, No. 91 Tianchi Road, Tianshan District, Urumqi, 830001, Xinjiang Uygur Autonomous Region, China. wwlj330@126.com.
  • Liu HL; Department of Rheumatology and Immunology, Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, No. 197 Ruijin Second Road, Huangpu District, Shanghai, 200025, China. hong-lei-liu@163.com.
Clin Rheumatol ; 38(1): 107-115, 2019 Jan.
Article en En | MEDLINE | ID: mdl-30123930
ABSTRACT
To estimate the mortality and describe the causes of death in a large multicenter cohort of hospitalized patients with SLE in China. This was a retrospective study of a nationwide SLE cohort (10 centers, 29,510 hospitalized patients) from 2005 to 2014 in China. Standardized mortality ratios (SMRs) were calculated for all death and were stratified by sex and age. Chi-square test was used to determine whether the major causes of death vary in age, sex, duration of SLE, disease activity, or medications. Comparison between dead patients and survival controls was used to identify the risk factors for mortality. Logistic regression analysis was used to evaluate the risk factors for mortality. A total of 360 patients died during the study period, accounting for 1.22%. The overall SMR was 2.13 (95% CI 1.96, 2.30), with a particularly high SMR seen in subgroups characterized by younger age. Infection (65.8%) was the most common cause of death, followed by lupus nephritis (48.6%), hematological abnormality (18.1%), neuropsychiatric lupus/NPSLE (15.8%), and interstitial pneumonia (13.1%). Cardiovascular disease and malignancy contributed little to the causes of death. Infection, in particular severe pulmonary infection, emerged as the foremost risk factor for mortality, followed by lupus encephalopathy. However, lupus nephritis and hematological abnormalities occurred more frequently in survival patients. SLE patients at a younger age of diagnosis have a poorer prognosis. Infection dominated the causes of death in recent China. Ethnicity and medications might account for the differences in causes of death compared with western populations.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Causas de Muerte / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Clin Rheumatol Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Causas de Muerte / Lupus Eritematoso Sistémico Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Clin Rheumatol Año: 2019 Tipo del documento: Article País de afiliación: China